{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:19:44Z","timestamp":1793773184962,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.gassur.2023.10.002","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T02:26:51Z","timestamp":1705804011000},"page":"18-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"28","author":[{"given":"Jun","family":"Kawashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Sahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Aldrighetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin","family":"Alexandrescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Poultsides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishir K.","family":"Maithel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo P.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Pulitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Cauchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Groot","family":"Koerkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusei","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.gassur.2023.10.002_bib1","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00268-019-04966-4","article-title":"Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival","volume":"43","author":"Wu","year":"2019","journal-title":"World J Surg"},{"issue":"7","key":"10.1016\/j.gassur.2023.10.002_bib2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00432-010-0971-z","article-title":"Intra-hepatic cholangiocarcinoma--frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center","volume":"137","author":"Singal","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2023.10.002_bib3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1245\/s10434-007-9627-x","article-title":"Surgical management of intrahepatic cholangiocarcinoma--a population-based study","volume":"15","author":"Tan","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2023.10.002_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejso.2014.09.007","article-title":"Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis","volume":"41","author":"Al-Adra","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.gassur.2023.10.002_bib5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.surg.2017.09.058","article-title":"Outcomes of resection for solitary \u22645 cm intrahepatic cholangiocarcinoma","volume":"163","author":"Tarchi","year":"2018","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.gassur.2023.10.002_bib6","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1245\/s10434-020-09478-3","article-title":"Neoadjuvant chemotherapy for intrahepatic cholangiocarcinoma: a propensity score survival analysis supporting use in patients with high-risk disease","volume":"28","author":"Utuama","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2023.10.002_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jhep.2022.10.021","article-title":"Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma","volume":"78","author":"Sposito","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.gassur.2023.10.002_bib8","unstructured":"Liver Cancer Study Group of Japan. LCSGJ ICC Guidelines 2021. Japan Council for Quality Health Care; 2021. Available from: \u3008https:\/\/minds.jcqhc.or.jp\/n\/med\/4\/med0463\/G0001265\u3009. [accessed 10 Aug 2023]."},{"key":"10.1016\/j.gassur.2023.10.002_bib9","unstructured":"National Comprehensive Cancer Network. Hepatobiliary cancer. version 2.2023; 2023. Available from: \u3008https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hepatobiliary.pdf\u3009. [accessed 10 Aug 2023]."},{"issue":"3","key":"10.1016\/j.gassur.2023.10.002_bib10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/biostatistics\/kxl030","article-title":"Estimating and modeling the cure fraction in population-based cancer survival analysis","volume":"8","author":"Lambert","year":"2007","journal-title":"Biostatistics"},{"issue":"22","key":"10.1016\/j.gassur.2023.10.002_bib11","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1002\/cncr.29619","article-title":"Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?","volume":"121","author":"Spolverato","year":"2015","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.gassur.2023.10.002_bib12","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s11605-020-04833-x","article-title":"Reappraisal of the T category for solitary intrahepatic cholangiocarcinoma by tumor size in 611 early-stage (T1-2N0M0) patients after hepatectomy: a Surveillance, Epidemiology, and End Results (SEER) analysis","volume":"25","author":"Chen","year":"2021","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.gassur.2023.10.002_bib13","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.gassur.2023.10.002_bib14","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/aje\/kwp425","article-title":"Multiple imputation for missing data: fully conditional specification versus multivariate normal imputation","volume":"171","author":"Lee","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"21","key":"10.1016\/j.gassur.2023.10.002_bib15","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"7355","key":"10.1016\/j.gassur.2023.10.002_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.gassur.2023.10.002_bib17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jamasurg.2020.1973","article-title":"Very early recurrence after liver resection for intrahepatic cholangiocarcinoma: considering alternative treatment approaches","volume":"155","author":"Tsilimigras","year":"2020","journal-title":"JAMA Surg"},{"issue":"7","key":"10.1016\/j.gassur.2023.10.002_bib18","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/annonc\/mdq650","article-title":"A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score","volume":"22","author":"Jiang","year":"2011","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.gassur.2023.10.002_bib19","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/bjs.10676","article-title":"Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent","volume":"105","author":"Zhang","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.gassur.2023.10.002_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00360","article-title":"Novel nomogram for preoperative prediction of early recurrence in intrahepatic cholangiocarcinoma","volume":"8","author":"Liang","year":"2018","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2023.10.002_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/AS9.0000000000000328","article-title":"Call to improve the quality of prediction tools for intrahepatic cholangiocarcinoma resection: a critical appraisal, systematic review, and external validation study","volume":"4","author":"Choi","year":"2023","journal-title":"Ann Surg Open"},{"issue":"5","key":"10.1016\/j.gassur.2023.10.002_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.0117","article-title":"Development and validation of a prognostic score for intrahepatic cholangiocarcinoma","volume":"152","author":"Raoof","year":"2017","journal-title":"JAMA Surg"},{"issue":"12","key":"10.1016\/j.gassur.2023.10.002_bib23","article-title":"Blood CEA levels for detecting recurrent colorectal cancer","volume":"12","author":"Nicholson","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.gassur.2023.10.002_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1155\/2013\/196412","article-title":"Serum markers of intrahepatic cholangiocarcinoma","volume":"34","author":"Malaguarnera","year":"2013","journal-title":"Dis Markers"},{"issue":"8","key":"10.1016\/j.gassur.2023.10.002_bib25","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1245\/s10434-020-08350-8","article-title":"The impact of preoperative CA19-9 and CEA on outcomes of patients with intrahepatic cholangiocarcinoma","volume":"27","author":"Moro","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.gassur.2023.10.002_bib26","first-page":"265","article-title":"A new radioimmunoassay detecting early stages of colon cancer: a comparison with CEA, AFP, and Ca 19-9","volume":"9","author":"Chester","year":"1991","journal-title":"Dis Markers"},{"issue":"6","key":"10.1016\/j.gassur.2023.10.002_bib27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.gassur.2023.10.002_bib28","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.gassur.2023.10.002_bib29","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.hpb.2020.03.011","article-title":"The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis","volume":"22","author":"Tsilimigras","year":"2020","journal-title":"HPB"},{"issue":"12","key":"10.1016\/j.gassur.2023.10.002_bib30","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.1245\/s10434-022-12058-2","article-title":"Prognostic utility of systemic immune-inflammation index after resection of extrahepatic cholangiocarcinoma: results from the U.S. Extrahepatic Biliary Malignancy Consortium","volume":"29","author":"Toyoda","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.gassur.2023.10.002_bib31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","article-title":"Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes","volume":"144","author":"Sia","year":"2013","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1016\/j.gassur.2023.10.002_bib32","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1245\/s10434-020-08696-z","article-title":"A novel classification of intrahepatic cholangiocarcinoma phenotypes using machine learning techniques: an international multi-institutional analysis","volume":"27","author":"Tsilimigras","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.gassur.2023.10.002_bib33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"10372","key":"10.1016\/j.gassur.2023.10.002_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","article-title":"Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"401","author":"Nakachi","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gassur.2023.10.002_bib35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jjco\/hyy190","article-title":"Randomized phase II\/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02\/JSAP05)","volume":"49","author":"Motoi","year":"2019","journal-title":"Jpn J Clin Oncol"},{"issue":"8","key":"10.1016\/j.gassur.2023.10.002_bib36","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.gassur.2023.10.002_bib37","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.1245\/s10434-023-14254-0","article-title":"Great debates: neoadjuvant therapy should be routinely given for high-risk cholangiocarcinoma","volume":"30","author":"Tran Cao","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.gassur.2023.10.002_bib38","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1245\/s10434-023-13567-4","article-title":"Trends in receipt of adjuvant chemotherapy and its impact on survival in resected biliary tract cancers","volume":"30","author":"Rhodin","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2023.10.002_bib39","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1245\/s10434-019-07483-9","article-title":"Therapeutic index associated with lymphadenectomy among patients with intrahepatic cholangiocarcinoma: which patients benefit the most from nodal evaluation?","volume":"26","author":"Sahara","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.gassur.2023.10.002_bib40","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/bjs.10827","article-title":"Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma","volume":"105","author":"Zhang","year":"2018","journal-title":"Br J Surg"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T15:30:33Z","timestamp":1764257433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1091255X23000021"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2023.10.002","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2023.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}